Clinical Trials Logo

Clinical Trial Summary

To collect the efficacy and safety informations of voriconazole related to their appropriate use in daily practice.


Clinical Trial Description

All the subjects whom an investigator prescribes the first voriconazole (VFEND) should be registered consecutively until the number of subjects reaches target number in order to extract subjects enrolled into the investigation at random. ;


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01151085
Study type Observational
Source Pfizer
Contact
Status Completed
Phase N/A
Start date April 2006
Completion date May 2012

See also
  Status Clinical Trial Phase
Completed NCT02492594 - Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections